Serial Platelet Function-Guided Antiplatelet Modulation After STEMI: A Randomized Pilot Study
Journal of Cardiovascular Pharmacology and Therapeutics · 2026
DOI: 10.1177/10742484261483397 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, 2026. Verfasst von Hrvoje Jurin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, University Hospital Centre Zagreb (UHC Zagreb), Zagreb, Croatia. Hauptthemen laut MEDLINE: Adenosine Diphosphate, Blood Platelets, Clopidogrel, Platelet Aggregation Inhibitors. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Platelet reactivity varies after ST-segment-elevation myocardial infarction (STEMI). We evaluated serial platelet function-guided P2Y12 modulation after a 1-month ticagrelor run-in.
Methods
At month 1, 114 patients were randomized to continued ticagrelor (n=59) or an adenosine diphosphate (ADP)-guided strategy (n=55). Month-1 ADP was the preintervention baseline; months 2, 3, 6, 9, and 12 were analyzed using baseline-adjusted generalized estimating equations. Exploratory net adverse clinical events (NACE) were assessed from randomization through month 12 after STEMI.
Results
In the guided group, month-1 ADP was 52 U (range, 4-466); 37 patients received clopidogrel 75 mg and 18 received 150 mg, with 17 dose-threshold discordances. Adjusted postrandomization ADP was higher with the guided strategy (geometric mean ratio, 1.26; 95% confidence interval [CI], 1.05-1.51). NACE occurred in 14/59 versus 4/55 patients (risk ratio [RR], 0.31; 95% CI, 0.11-0.87; absolute risk difference, -16.5 percentage points; exact P=.020). Any investigator-classified BARC bleeding occurred in 13/59 versus 3/55 (RR, 0.25; 95% CI, 0.07-0.82; exact P=.014), and the post hoc ischemic-or-BARC ≥2 composite in 9/59 versus 2/55 (RR, 0.24; 95% CI, 0.05-1.06; exact P=.055). One ischemic event occurred in each group.
Conclusions
Serial ADP-guided modulation produced pharmacodynamic separation and was associated with fewer investigator-recorded, bleeding-driven events. Dose-threshold deviations, unverified extreme ADP values, incomplete BARC 2 documentation, and only 2 ischemic events restrict interpretation to hypothesis generation; efficacy and safety cannot be established.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Diseases, University Hospital Centre Zagreb (UHC Zagreb), Zagreb, Croatia.
- Department of Cardiovascular Diseases, Dubrava University Hospital, Zagreb, Croatia.
- Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
- University of Zagreb School of Medicine, Zagreb, Croatia.
- Algebra Bernays University, Zagreb, Croatia.
- Magdalena Clinic for Cardiovascular Diseases, Krapinske Toplice, Croatia.
ORCID-Profile: Hrvoje Jurin, Irzal Hadžibegović, Boško Skorić
Zitieren
APA
Jurin, H., Hadžibegović, I., Samardžić, J., Bulum, J., Skorić, B., Čikeš, M., Planinc, I., Ostojić, Z., Tagasovski, I., & Miličić, D. (2026). Serial Platelet Function-Guided Antiplatelet Modulation After STEMI: A Randomized Pilot Study. Journal of Cardiovascular Pharmacology and Therapeutics. https://doi.org/10.1177/10742484261483397
Vancouver
Jurin H, Hadžibegović I, Samardžić J, Bulum J, Skorić B, Čikeš M, et al. Serial Platelet Function-Guided Antiplatelet Modulation After STEMI: A Randomized Pilot Study. Journal of Cardiovascular Pharmacology and Therapeutics. 2026. doi:10.1177/10742484261483397
BibTeX
@article{Jurin2026,
author = {Jurin, Hrvoje and Hadžibegović, Irzal and Samardžić, Jure and Bulum, Joško and Skorić, Boško and Čikeš, Maja and Planinc, Ivo and Ostojić, Zvonimir and Tagasovski, Igor and Miličić, Davor},
title = {Serial Platelet Function-Guided Antiplatelet Modulation After STEMI: A Randomized Pilot Study},
journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
year = {2026},
doi = {10.1177/10742484261483397}
}
EUVIMED